IL294071A - Methods of treating conditions related to the s1p1 receptor - Google Patents

Info

Publication number

IL294071A

IL294071A IL294071A IL29407122A IL294071A IL 294071 A IL294071 A IL 294071A IL 294071 A IL294071 A IL 294071A IL 29407122 A IL29407122 A IL 29407122A IL 294071 A IL294071 A IL 294071A

Authority

IL

Israel

Prior art keywords

compound

individual

pharmaceutically acceptable

acceptable salt

administered

Prior art date

2020-01-06

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title claims description 119
• 102000011011 Sphingosine 1-phosphate receptors Human genes 0.000 title description 2
• 108050001083 Sphingosine 1-phosphate receptors Proteins 0.000 title description 2
• 229940125904 compound 1 Drugs 0.000 claims description 168
• 150000003839 salts Chemical class 0.000 claims description 130
• 208000004631 alopecia areata Diseases 0.000 claims description 76
• 238000011282 treatment Methods 0.000 claims description 68
• 150000001875 compounds Chemical class 0.000 claims description 55
• 239000000090 biomarker Substances 0.000 claims description 52
• 239000003814 drug Substances 0.000 claims description 47
• 230000004044 response Effects 0.000 claims description 47
• 201000004384 Alopecia Diseases 0.000 claims description 45
• 210000004761 scalp Anatomy 0.000 claims description 38
• 238000002560 therapeutic procedure Methods 0.000 claims description 37
• 230000006872 improvement Effects 0.000 claims description 36
• AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 claims description 36
• 229940124597 therapeutic agent Drugs 0.000 claims description 28
• 230000003676 hair loss Effects 0.000 claims description 27
• 208000024963 hair loss Diseases 0.000 claims description 25
• 230000001939 inductive effect Effects 0.000 claims description 19
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
• 239000002552 dosage form Substances 0.000 claims description 17
• 239000002775 capsule Substances 0.000 claims description 15
• 231100000360 alopecia Toxicity 0.000 claims description 14
• 230000008859 change Effects 0.000 claims description 13
• 125000002059 L-arginyl group Chemical class O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 claims description 12
• 230000009467 reduction Effects 0.000 claims description 11
• 238000012544 monitoring process Methods 0.000 claims description 9
• 108050003558 Interleukin-17 Proteins 0.000 claims description 8
• 102000013691 Interleukin-17 Human genes 0.000 claims description 8
• 206010003671 Atrioventricular Block Diseases 0.000 claims description 7
• 230000001154 acute effect Effects 0.000 claims description 7
• 238000004448 titration Methods 0.000 claims description 7
• 102000003816 Interleukin-13 Human genes 0.000 claims description 6
• 108090000176 Interleukin-13 Proteins 0.000 claims description 6
• 208000010271 Heart Block Diseases 0.000 claims description 5
• 239000004480 active ingredient Substances 0.000 claims description 5
• 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 claims description 5
• 102000003814 Interleukin-10 Human genes 0.000 claims description 4
• 108090000174 Interleukin-10 Proteins 0.000 claims description 4
• 108010065805 Interleukin-12 Proteins 0.000 claims description 4
• 102000013462 Interleukin-12 Human genes 0.000 claims description 4
• 102100030703 Interleukin-22 Human genes 0.000 claims description 4
• 230000002411 adverse Effects 0.000 claims description 4
• 159000000007 calcium salts Chemical class 0.000 claims description 4
• 108010074109 interleukin-22 Proteins 0.000 claims description 4
• 231100001079 no serious adverse effect Toxicity 0.000 claims description 4
• 108010002350 Interleukin-2 Proteins 0.000 claims description 3
• 102000000588 Interleukin-2 Human genes 0.000 claims description 3
• 201000008150 diffuse alopecia areata Diseases 0.000 claims description 3
• 239000012453 solvate Substances 0.000 description 93
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 44
• 201000010099 disease Diseases 0.000 description 32
• 208000024891 symptom Diseases 0.000 description 31
• 210000003780 hair follicle Anatomy 0.000 description 29
• 230000001965 increasing effect Effects 0.000 description 26
• 108090000623 proteins and genes Proteins 0.000 description 25
• 210000004209 hair Anatomy 0.000 description 23
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 22
• 230000000694 effects Effects 0.000 description 21
• 239000003826 tablet Substances 0.000 description 18
• 230000000699 topical effect Effects 0.000 description 18
• 102000005962 receptors Human genes 0.000 description 17
• 108020003175 receptors Proteins 0.000 description 17
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 17
• 239000000203 mixture Substances 0.000 description 16
• 238000012216 screening Methods 0.000 description 15
• 229940079593 drug Drugs 0.000 description 14
• 230000003698 anagen phase Effects 0.000 description 12
• 208000035475 disorder Diseases 0.000 description 12
• -1 (trifluoromethyl)benzyloxy Chemical group 0.000 description 11
• 102000011782 Keratins Human genes 0.000 description 11
• 108010076876 Keratins Proteins 0.000 description 11
• 230000014509 gene expression Effects 0.000 description 11
• 150000004677 hydrates Chemical class 0.000 description 11
• 239000008194 pharmaceutical composition Substances 0.000 description 11
• 102000004169 proteins and genes Human genes 0.000 description 11
• 210000003491 skin Anatomy 0.000 description 11
• BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 10
• 230000036541 health Effects 0.000 description 10
• 235000018102 proteins Nutrition 0.000 description 10
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
• 238000011443 conventional therapy Methods 0.000 description 9
• 230000009885 systemic effect Effects 0.000 description 9
• 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 8
• 108010082126 Alanine transaminase Proteins 0.000 description 8
• 108010003415 Aspartate Aminotransferases Proteins 0.000 description 8
• 102000004625 Aspartate Aminotransferases Human genes 0.000 description 8
• 239000003795 chemical substances by application Substances 0.000 description 8
• BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 8
• 230000003659 hair regrowth Effects 0.000 description 8
• 239000000843 powder Substances 0.000 description 8
• 102100025750 Sphingosine 1-phosphate receptor 1 Human genes 0.000 description 7
• 230000027455 binding Effects 0.000 description 7
• 230000031774 hair cycle Effects 0.000 description 7
• 230000002265 prevention Effects 0.000 description 7
• 230000033764 rhythmic process Effects 0.000 description 7
• 239000000523 sample Substances 0.000 description 7
• 239000007787 solid Substances 0.000 description 7
• 239000002904 solvent Substances 0.000 description 7
• 229940122245 Janus kinase inhibitor Drugs 0.000 description 6
• 101710155454 Sphingosine 1-phosphate receptor 1 Proteins 0.000 description 6
• 239000002253 acid Substances 0.000 description 6
• 239000000427 antigen Substances 0.000 description 6
• 108091007433 antigens Proteins 0.000 description 6
• 102000036639 antigens Human genes 0.000 description 6
• 230000002500 effect on skin Effects 0.000 description 6
• 239000000902 placebo Substances 0.000 description 6
• 229940068196 placebo Drugs 0.000 description 6
• 229920001184 polypeptide Polymers 0.000 description 6
• 102000004196 processed proteins & peptides Human genes 0.000 description 6
• 108090000765 processed proteins & peptides Proteins 0.000 description 6
• 206010001766 Alopecia totalis Diseases 0.000 description 5
• 102000019034 Chemokines Human genes 0.000 description 5
• 108010012236 Chemokines Proteins 0.000 description 5
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 5
• 108060003951 Immunoglobulin Proteins 0.000 description 5
• 108010050904 Interferons Proteins 0.000 description 5
• 102000014150 Interferons Human genes 0.000 description 5
• 102000000834 NK Cell Lectin-Like Receptor Subfamily C Human genes 0.000 description 5
• 108010001880 NK Cell Lectin-Like Receptor Subfamily C Proteins 0.000 description 5
• 102000001712 STAT5 Transcription Factor Human genes 0.000 description 5
• 108010029477 STAT5 Transcription Factor Proteins 0.000 description 5
• 206010047700 Vomiting Diseases 0.000 description 5
• 230000002159 abnormal effect Effects 0.000 description 5
• 210000004027 cell Anatomy 0.000 description 5
• 230000001684 chronic effect Effects 0.000 description 5
• 239000003246 corticosteroid Substances 0.000 description 5
• 238000009472 formulation Methods 0.000 description 5
• 102000018358 immunoglobulin Human genes 0.000 description 5
• 229940079322 interferon Drugs 0.000 description 5
• 239000003446 ligand Substances 0.000 description 5
• 238000002360 preparation method Methods 0.000 description 5
• 230000003612 virological effect Effects 0.000 description 5
• OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 4
• MVGWUTBTXDYMND-QGZVFWFLSA-N 2-[(3r)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid Chemical compound C([C@@H]1CC(=O)O)CC(C2=C3)=C1NC2=CC=C3OCC(C=C1C(F)(F)F)=CC=C1C1CCCC1 MVGWUTBTXDYMND-QGZVFWFLSA-N 0.000 description 4
• 206010001767 Alopecia universalis Diseases 0.000 description 4
• 102000005600 Cathepsins Human genes 0.000 description 4
• 108010084457 Cathepsins Proteins 0.000 description 4
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 4
• 108010036949 Cyclosporine Proteins 0.000 description 4
• 108010008165 Etanercept Proteins 0.000 description 4
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 4
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 4
• 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 description 4
• 206010019233 Headaches Diseases 0.000 description 4
• 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 description 4
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 4
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 4
• 102100021747 Leukemia inhibitory factor receptor Human genes 0.000 description 4
• 238000003559 RNA-seq method Methods 0.000 description 4
• 102000037054 SLC-Transporter Human genes 0.000 description 4
• 108091006207 SLC-Transporter Proteins 0.000 description 4
• 102100038081 Signal transducer CD24 Human genes 0.000 description 4
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 4
• 208000032775 alopecia universalis congenita Diseases 0.000 description 4
• IMOZEMNVLZVGJZ-QGZVFWFLSA-N apremilast Chemical compound C1=C(OC)C(OCC)=CC([C@@H](CS(C)(=O)=O)N2C(C3=C(NC(C)=O)C=CC=C3C2=O)=O)=C1 IMOZEMNVLZVGJZ-QGZVFWFLSA-N 0.000 description 4
• 230000036772 blood pressure Effects 0.000 description 4
• 230000003778 catagen phase Effects 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 4
• 229960003692 gamma aminobutyric acid Drugs 0.000 description 4
• 231100000869 headache Toxicity 0.000 description 4
• 210000002865 immune cell Anatomy 0.000 description 4
• 230000002757 inflammatory effect Effects 0.000 description 4
• 230000000670 limiting effect Effects 0.000 description 4
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
• 239000011159 matrix material Substances 0.000 description 4
• 229960000485 methotrexate Drugs 0.000 description 4
• 230000035479 physiological effects, processes and functions Effects 0.000 description 4
• 210000004918 root sheath Anatomy 0.000 description 4
• UJLAWZDWDVHWOW-YPMHNXCESA-N tofacitinib Chemical compound C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)C1=NC=NC2=C1C=CN2 UJLAWZDWDVHWOW-YPMHNXCESA-N 0.000 description 4
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 4
• 239000003981 vehicle Substances 0.000 description 4
• 230000008673 vomiting Effects 0.000 description 4
• MJZJYWCQPMNPRM-UHFFFAOYSA-N 6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine Chemical compound CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC(Cl)=C(Cl)C=C1Cl MJZJYWCQPMNPRM-UHFFFAOYSA-N 0.000 description 3
• 102100030346 Antigen peptide transporter 1 Human genes 0.000 description 3
• 208000019901 Anxiety disease Diseases 0.000 description 3
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 3
• 208000003950 B-cell lymphoma Diseases 0.000 description 3
• 102100023702 C-C motif chemokine 13 Human genes 0.000 description 3
• 108091008927 CC chemokine receptors Proteins 0.000 description 3
• 102000005674 CCR Receptors Human genes 0.000 description 3
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 3
• 102000014914 Carrier Proteins Human genes 0.000 description 3
• 108010078791 Carrier Proteins Proteins 0.000 description 3
• 102100028914 Catenin beta-1 Human genes 0.000 description 3
• 102000010970 Connexin Human genes 0.000 description 3
• 108050001175 Connexin Proteins 0.000 description 3
• 102000030914 Fatty Acid-Binding Human genes 0.000 description 3
• 102000004315 Forkhead Transcription Factors Human genes 0.000 description 3
• 108090000852 Forkhead Transcription Factors Proteins 0.000 description 3
• 108091006027 G proteins Proteins 0.000 description 3
• 102000030782 GTP binding Human genes 0.000 description 3
• 108091000058 GTP-Binding Proteins 0.000 description 3
• 102000003693 Hedgehog Proteins Human genes 0.000 description 3
• 108090000031 Hedgehog Proteins Proteins 0.000 description 3
• 241000711549 Hepacivirus C Species 0.000 description 3
• 102100030690 Histone H2B type 1-C/E/F/G/I Human genes 0.000 description 3
• 101000652570 Homo sapiens Antigen peptide transporter 1 Proteins 0.000 description 3
• 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 description 3
• 101000916173 Homo sapiens Catenin beta-1 Proteins 0.000 description 3
• 101001084682 Homo sapiens Histone H2B type 1-C/E/F/G/I Proteins 0.000 description 3
• 101001046683 Homo sapiens Integrin alpha-L Proteins 0.000 description 3
• 101001042362 Homo sapiens Leukemia inhibitory factor receptor Proteins 0.000 description 3
• 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 description 3
• 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 description 3
• 101000987581 Homo sapiens Perforin-1 Proteins 0.000 description 3
• 206010061218 Inflammation Diseases 0.000 description 3
• 102100022339 Integrin alpha-L Human genes 0.000 description 3
• 102000015696 Interleukins Human genes 0.000 description 3
• 108010063738 Interleukins Proteins 0.000 description 3
• 101150009057 JAK2 gene Proteins 0.000 description 3
• 101150069380 JAK3 gene Proteins 0.000 description 3
• 108700003486 Jagged-1 Proteins 0.000 description 3
• 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 3
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 3
• 208000001344 Macular Edema Diseases 0.000 description 3
• 206010025415 Macular oedema Diseases 0.000 description 3
• ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 3
• 108700020796 Oncogene Proteins 0.000 description 3
• 102100028467 Perforin-1 Human genes 0.000 description 3
• 102100032702 Protein jagged-1 Human genes 0.000 description 3
• 201000004681 Psoriasis Diseases 0.000 description 3
• 108010044012 STAT1 Transcription Factor Proteins 0.000 description 3
• 102000004265 STAT2 Transcription Factor Human genes 0.000 description 3
• 108010081691 STAT2 Transcription Factor Proteins 0.000 description 3
• 108010017324 STAT3 Transcription Factor Proteins 0.000 description 3
• 102000005886 STAT4 Transcription Factor Human genes 0.000 description 3
• 108010019992 STAT4 Transcription Factor Proteins 0.000 description 3
• 102000013968 STAT6 Transcription Factor Human genes 0.000 description 3
• 108010011005 STAT6 Transcription Factor Proteins 0.000 description 3
• 102100029904 Signal transducer and activator of transcription 1-alpha/beta Human genes 0.000 description 3
• 102100024040 Signal transducer and activator of transcription 3 Human genes 0.000 description 3
• 102100029802 Sphingosine 1-phosphate receptor 5 Human genes 0.000 description 3
• 101710155451 Sphingosine 1-phosphate receptor 5 Proteins 0.000 description 3
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 3
• 210000001744 T-lymphocyte Anatomy 0.000 description 3
• 239000004012 Tofacitinib Substances 0.000 description 3
• 230000003213 activating effect Effects 0.000 description 3
• 229960002964 adalimumab Drugs 0.000 description 3
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 3
• 229960002170 azathioprine Drugs 0.000 description 3
• 230000009286 beneficial effect Effects 0.000 description 3
• 239000011230 binding agent Substances 0.000 description 3
• 108091008324 binding proteins Proteins 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 230000036471 bradycardia Effects 0.000 description 3
• 208000006218 bradycardia Diseases 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 239000001913 cellulose Substances 0.000 description 3
• 229920002678 cellulose Polymers 0.000 description 3
• 229960001265 ciclosporin Drugs 0.000 description 3
• 229930182912 cyclosporin Natural products 0.000 description 3
• 230000004069 differentiation Effects 0.000 description 3
• HCIBTBXNLVOFER-UHFFFAOYSA-N diphenylcyclopropenone Chemical compound O=C1C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 HCIBTBXNLVOFER-UHFFFAOYSA-N 0.000 description 3
• 229950003468 dupilumab Drugs 0.000 description 3
• 229940069604 etrasimod Drugs 0.000 description 3
• 230000007717 exclusion Effects 0.000 description 3
• 108091022862 fatty acid binding Proteins 0.000 description 3
• 210000004905 finger nail Anatomy 0.000 description 3
• 239000012458 free base Substances 0.000 description 3
• 230000003779 hair growth Effects 0.000 description 3
• 238000009169 immunotherapy Methods 0.000 description 3
• 208000015181 infectious disease Diseases 0.000 description 3
• 230000004054 inflammatory process Effects 0.000 description 3
• 238000007449 liver function test Methods 0.000 description 3
• 201000010230 macular retinal edema Diseases 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 238000002483 medication Methods 0.000 description 3
• 239000010445 mica Substances 0.000 description 3
• 229910052618 mica group Inorganic materials 0.000 description 3
• 229960003632 minoxidil Drugs 0.000 description 3
• 231100000252 nontoxic Toxicity 0.000 description 3
• 230000003000 nontoxic effect Effects 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 230000037390 scarring Effects 0.000 description 3
• 229960004540 secukinumab Drugs 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• DUYSYHSSBDVJSM-KRWOKUGFSA-N sphingosine 1-phosphate Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(O)(O)=O DUYSYHSSBDVJSM-KRWOKUGFSA-N 0.000 description 3
• 150000003431 steroids Chemical class 0.000 description 3
• 229960001350 tofacitinib Drugs 0.000 description 3
• 229960003824 ustekinumab Drugs 0.000 description 3
• WYQFJHHDOKWSHR-MNOVXSKESA-N (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide Chemical compound CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1C1=CN=C2N1C(C=CN1)=C1N=C2 WYQFJHHDOKWSHR-MNOVXSKESA-N 0.000 description 2
• KTBSXLIQKWEBRB-UHFFFAOYSA-N 2-[1-[1-[3-fluoro-2-(trifluoromethyl)pyridine-4-carbonyl]piperidin-4-yl]-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile Chemical compound C1=CN=C(C(F)(F)F)C(F)=C1C(=O)N1CCC(N2CC(CC#N)(C2)N2N=CC(=C2)C=2C=3C=CNC=3N=CN=2)CC1 KTBSXLIQKWEBRB-UHFFFAOYSA-N 0.000 description 2
• PDOQBOJDRPLBQU-QMMMGPOBSA-N 5-chloro-2-n-[(1s)-1-(5-fluoropyrimidin-2-yl)ethyl]-4-n-(5-methyl-1h-pyrazol-3-yl)pyrimidine-2,4-diamine Chemical compound N([C@@H](C)C=1N=CC(F)=CN=1)C(N=1)=NC=C(Cl)C=1NC=1C=C(C)NN=1 PDOQBOJDRPLBQU-QMMMGPOBSA-N 0.000 description 2
• 208000004998 Abdominal Pain Diseases 0.000 description 2
• 102100036775 Afadin Human genes 0.000 description 2
• 201000011374 Alagille syndrome Diseases 0.000 description 2
• 208000008035 Back Pain Diseases 0.000 description 2
• 108090000342 C-Type Lectins Proteins 0.000 description 2
• 102000003930 C-Type Lectins Human genes 0.000 description 2
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 2
• 108010041397 CD4 Antigens Proteins 0.000 description 2
• 102100035793 CD83 antigen Human genes 0.000 description 2
• 108090000312 Calcium Channels Proteins 0.000 description 2
• 102000003922 Calcium Channels Human genes 0.000 description 2
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
• 102000016917 Complement C1 Human genes 0.000 description 2
• 108010028774 Complement C1 Proteins 0.000 description 2
• 206010010774 Constipation Diseases 0.000 description 2
• 229920002261 Corn starch Polymers 0.000 description 2
• 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
• 102000003849 Cytochrome P450 Human genes 0.000 description 2
• 206010012438 Dermatitis atopic Diseases 0.000 description 2
• 206010012735 Diarrhoea Diseases 0.000 description 2
• 108010009900 Endothelial Protein C Receptor Proteins 0.000 description 2
• 102000009839 Endothelial Protein C Receptor Human genes 0.000 description 2
• 102100030024 Endothelial protein C receptor Human genes 0.000 description 2
• 102000004190 Enzymes Human genes 0.000 description 2
• 108090000790 Enzymes Proteins 0.000 description 2
• 102000050554 Eph Family Receptors Human genes 0.000 description 2
• 108091008815 Eph receptors Proteins 0.000 description 2
• 102100039835 Galactoside alpha-(1,2)-fucosyltransferase 1 Human genes 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• 102100030385 Granzyme B Human genes 0.000 description 2
• 102100029966 HLA class II histocompatibility antigen, DP alpha 1 chain Human genes 0.000 description 2
• 102100036241 HLA class II histocompatibility antigen, DQ beta 1 chain Human genes 0.000 description 2
• 206010019280 Heart failures Diseases 0.000 description 2
• 108010033040 Histones Proteins 0.000 description 2
• 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 2
• 101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 2
• 101001012038 Homo sapiens Endothelial protein C receptor Proteins 0.000 description 2
• 101001009603 Homo sapiens Granzyme B Proteins 0.000 description 2
• 101000864089 Homo sapiens HLA class II histocompatibility antigen, DP alpha 1 chain Proteins 0.000 description 2
• 101000930800 Homo sapiens HLA class II histocompatibility antigen, DQ beta 1 chain Proteins 0.000 description 2
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 2
• 101000988394 Homo sapiens PDZ and LIM domain protein 5 Proteins 0.000 description 2
• 101001125939 Homo sapiens Plakophilin-1 Proteins 0.000 description 2
• 101000596046 Homo sapiens Plastin-2 Proteins 0.000 description 2
• 101000666172 Homo sapiens Protein-glutamine gamma-glutamyltransferase E Proteins 0.000 description 2
• 101000633778 Homo sapiens SLAM family member 5 Proteins 0.000 description 2
• 101000946863 Homo sapiens T-cell surface glycoprotein CD3 delta chain Proteins 0.000 description 2
• 101000635958 Homo sapiens Transforming growth factor beta-2 proprotein Proteins 0.000 description 2
• 101000708573 Homo sapiens Y+L amino acid transporter 2 Proteins 0.000 description 2
• 101000935569 Homo sapiens Zinc finger protein basonuclin-1 Proteins 0.000 description 2
• 206010020751 Hypersensitivity Diseases 0.000 description 2
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 2
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 2
• 102100022338 Integrin alpha-M Human genes 0.000 description 2
• 102100025390 Integrin beta-2 Human genes 0.000 description 2
• 102000042838 JAK family Human genes 0.000 description 2
• 108091082332 JAK family Proteins 0.000 description 2
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical class OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
• UIARLYUEJFELEN-LROUJFHJSA-N LSM-1231 Chemical compound C12=C3N4C5=CC=CC=C5C3=C3C(=O)NCC3=C2C2=CC=CC=C2N1[C@]1(C)[C@](CO)(O)C[C@H]4O1 UIARLYUEJFELEN-LROUJFHJSA-N 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 208000019693 Lung disease Diseases 0.000 description 2
• 102100038210 Lymphocyte antigen 6 complex locus protein G6d Human genes 0.000 description 2
• 101710160635 Lymphocyte antigen 6 complex locus protein G6d Proteins 0.000 description 2
• 102100038226 Lymphocyte antigen 6 complex locus protein G6f Human genes 0.000 description 2
• 101710160706 Lymphocyte antigen 6 complex locus protein G6f Proteins 0.000 description 2
• 102000018247 Lymphocyte-specific proteins Human genes 0.000 description 2
• 108050007388 Lymphocyte-specific proteins Proteins 0.000 description 2
• 102000043129 MHC class I family Human genes 0.000 description 2
• 108091054437 MHC class I family Proteins 0.000 description 2
• 208000019255 Menstrual disease Diseases 0.000 description 2
• 108060004795 Methyltransferase Proteins 0.000 description 2
• 206010028813 Nausea Diseases 0.000 description 2
• 101100154895 Oryzias latipes tyr gene Proteins 0.000 description 2
• 102100029181 PDZ and LIM domain protein 5 Human genes 0.000 description 2
• 102100029331 Plakophilin-1 Human genes 0.000 description 2
• 108010057275 Plakophilins Proteins 0.000 description 2
• 102000003753 Plakophilins Human genes 0.000 description 2
• 102100035182 Plastin-2 Human genes 0.000 description 2
• 102000001253 Protein Kinase Human genes 0.000 description 2
• 108700037966 Protein jagged-1 Proteins 0.000 description 2
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
• 102100038094 Protein-glutamine gamma-glutamyltransferase E Human genes 0.000 description 2
• 102000000033 Purinergic Receptors Human genes 0.000 description 2
• 108010080192 Purinergic Receptors Proteins 0.000 description 2
• 206010039085 Rhinitis allergic Diseases 0.000 description 2
• 102100029216 SLAM family member 5 Human genes 0.000 description 2
• 206010039491 Sarcoma Diseases 0.000 description 2
• 108010029176 Sialic Acid Binding Ig-like Lectin 1 Proteins 0.000 description 2
• 102100032855 Sialoadhesin Human genes 0.000 description 2
• 108050001286 Somatostatin Receptor Proteins 0.000 description 2
• 102000011096 Somatostatin receptor Human genes 0.000 description 2
• 241000519995 Stachys sylvatica Species 0.000 description 2
• 229920002472 Starch Polymers 0.000 description 2
• 108091008874 T cell receptors Proteins 0.000 description 2
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
• 102100035891 T-cell surface glycoprotein CD3 delta chain Human genes 0.000 description 2
• 108060008245 Thrombospondin Proteins 0.000 description 2
• 102000002938 Thrombospondin Human genes 0.000 description 2
• 102000002689 Toll-like receptor Human genes 0.000 description 2
• 108020000411 Toll-like receptor Proteins 0.000 description 2
• 102100030737 Transforming growth factor beta-2 proprotein Human genes 0.000 description 2
• XCCTYIAWTASOJW-XVFCMESISA-N Uridine-5'-Diphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 XCCTYIAWTASOJW-XVFCMESISA-N 0.000 description 2
• 102000004603 Vesicle-Associated Membrane Protein 1 Human genes 0.000 description 2
• 108010017743 Vesicle-Associated Membrane Protein 1 Proteins 0.000 description 2
• 206010047642 Vitiligo Diseases 0.000 description 2
• 102100032803 Y+L amino acid transporter 2 Human genes 0.000 description 2
• 102100027904 Zinc finger protein basonuclin-1 Human genes 0.000 description 2
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 102000035181 adaptor proteins Human genes 0.000 description 2
• 108091005764 adaptor proteins Proteins 0.000 description 2
• 108010076838 afadin Proteins 0.000 description 2
• 208000026935 allergic disease Diseases 0.000 description 2
• 201000010105 allergic rhinitis Diseases 0.000 description 2
• 230000007815 allergy Effects 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 206010068168 androgenetic alopecia Diseases 0.000 description 2
• 201000002996 androgenic alopecia Diseases 0.000 description 2
• NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 229940125715 antihistaminic agent Drugs 0.000 description 2
• 239000000739 antihistaminic agent Substances 0.000 description 2
• 230000036506 anxiety Effects 0.000 description 2
• 229960001164 apremilast Drugs 0.000 description 2
• 201000008937 atopic dermatitis Diseases 0.000 description 2
• 210000003719 b-lymphocyte Anatomy 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 description 2
• 229960002470 bimatoprost Drugs 0.000 description 2
• 239000003124 biologic agent Substances 0.000 description 2
• 238000001574 biopsy Methods 0.000 description 2
• JCINBYQJBYJGDM-UHFFFAOYSA-N bms-911543 Chemical compound CCN1C(C(=O)N(C2CC2)C2CC2)=CC(C=2N(C)C=NC=22)=C1N=C2NC=1C=C(C)N(C)N=1 JCINBYQJBYJGDM-UHFFFAOYSA-N 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 239000001768 carboxy methyl cellulose Substances 0.000 description 2
• 208000022667 central centrifugal cicatricial alopecia Diseases 0.000 description 2
• 239000008120 corn starch Substances 0.000 description 2
• 229960001334 corticosteroids Drugs 0.000 description 2
• 229940010466 cosentyx Drugs 0.000 description 2
• 239000006071 cream Substances 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• 230000007812 deficiency Effects 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 230000003205 diastolic effect Effects 0.000 description 2
• 230000009266 disease activity Effects 0.000 description 2
• 229960002311 dithranol Drugs 0.000 description 2
• 229940073621 enbrel Drugs 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 229940088598 enzyme Drugs 0.000 description 2
• 229960000403 etanercept Drugs 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 230000003721 exogen phase Effects 0.000 description 2
• 210000000720 eyelash Anatomy 0.000 description 2
• 108010079306 galactoside 2-alpha-L-fucosyltransferase Proteins 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 239000003862 glucocorticoid Substances 0.000 description 2
• 229960001743 golimumab Drugs 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 210000000442 hair follicle cell Anatomy 0.000 description 2
• 210000003128 head Anatomy 0.000 description 2
• 229940048921 humira Drugs 0.000 description 2
• 239000012729 immediate-release (IR) formulation Substances 0.000 description 2
• 229940124622 immune-modulator drug Drugs 0.000 description 2
• 230000001506 immunosuppresive effect Effects 0.000 description 2
• 239000003018 immunosuppressive agent Substances 0.000 description 2
• 229940124589 immunosuppressive drug Drugs 0.000 description 2
• 229960000598 infliximab Drugs 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 102000006495 integrins Human genes 0.000 description 2
• 108010044426 integrins Proteins 0.000 description 2
• 102000010681 interleukin-8 receptors Human genes 0.000 description 2
• 108010038415 interleukin-8 receptors Proteins 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 229960005435 ixekizumab Drugs 0.000 description 2
• 210000002510 keratinocyte Anatomy 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 201000002364 leukopenia Diseases 0.000 description 2
• 231100001022 leukopenia Toxicity 0.000 description 2
• 230000003908 liver function Effects 0.000 description 2
• 239000007937 lozenge Substances 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 235000019359 magnesium stearate Nutrition 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 238000004949 mass spectrometry Methods 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 230000001404 mediated effect Effects 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 208000027531 mycobacterial infectious disease Diseases 0.000 description 2
• 230000008693 nausea Effects 0.000 description 2
• 208000004235 neutropenia Diseases 0.000 description 2
• 229940011530 otezla Drugs 0.000 description 2
• 230000007170 pathology Effects 0.000 description 2
• 239000013610 patient sample Substances 0.000 description 2
• 238000001126 phototherapy Methods 0.000 description 2
• 239000006187 pill Substances 0.000 description 2
• 229920001592 potato starch Polymers 0.000 description 2
• 238000000634 powder X-ray diffraction Methods 0.000 description 2
• 206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 description 2
• 230000002035 prolonged effect Effects 0.000 description 2
• 230000000069 prophylactic effect Effects 0.000 description 2
• 108060006633 protein kinase Proteins 0.000 description 2
• 230000009325 pulmonary function Effects 0.000 description 2
• 238000009613 pulmonary function test Methods 0.000 description 2
• 102000016914 ras Proteins Human genes 0.000 description 2
• 230000000306 recurrent effect Effects 0.000 description 2
• 229940116176 remicade Drugs 0.000 description 2
• 230000008439 repair process Effects 0.000 description 2
• 229960004641 rituximab Drugs 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• VXBAJLGYBMTJCY-NSCUHMNNSA-N sb1317 Chemical compound N=1C2=CC=NC=1NC(C=1)=CC=CC=1CN(C)C\C=C\CCOC1=CC=CC2=C1 VXBAJLGYBMTJCY-NSCUHMNNSA-N 0.000 description 2
• 229940068638 simponi Drugs 0.000 description 2
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 235000019698 starch Nutrition 0.000 description 2
• 229940071598 stelara Drugs 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• 229940060681 taltz Drugs 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• 238000002411 thermogravimetry Methods 0.000 description 2
• 229940125379 topical corticosteroid Drugs 0.000 description 2
• 102000035160 transmembrane proteins Human genes 0.000 description 2
• 108091005703 transmembrane proteins Proteins 0.000 description 2
• 201000008827 tuberculosis Diseases 0.000 description 2
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
• TUCIOBMMDDOEMM-RIYZIHGNSA-N tyrphostin B42 Chemical compound C1=C(O)C(O)=CC=C1\C=C(/C#N)C(=O)NCC1=CC=CC=C1 TUCIOBMMDDOEMM-RIYZIHGNSA-N 0.000 description 2
• 230000003827 upregulation Effects 0.000 description 2
• KIHYPELVXPAIDH-HNSNBQBZSA-N 1-[[4-[(e)-n-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-c-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidine-3-carboxylic acid Chemical compound CCC1=CC(C(\C)=N\OCC=2C=C(C(C3CCCCC3)=CC=2)C(F)(F)F)=CC=C1CN1CC(C(O)=O)C1 KIHYPELVXPAIDH-HNSNBQBZSA-N 0.000 description 1
• VSNHCAURESNICA-NJFSPNSNSA-N 1-oxidanylurea Chemical compound N[14C](=O)NO VSNHCAURESNICA-NJFSPNSNSA-N 0.000 description 1
• VOXBZHOHGGBLCQ-UHFFFAOYSA-N 2-amino-3,7-dihydropurine-6-thione;hydrate Chemical compound O.N1C(N)=NC(=S)C2=C1N=CN2.N1C(N)=NC(=S)C2=C1N=CN2 VOXBZHOHGGBLCQ-UHFFFAOYSA-N 0.000 description 1
• BGLPECHZZQDNCD-UHFFFAOYSA-N 4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide Chemical compound C1CN(S(=O)(=O)CC)CCN1C(C=C1)=CC=C1NC1=NC=C(C(N)=O)C(NC2CC2)=N1 BGLPECHZZQDNCD-UHFFFAOYSA-N 0.000 description 1
• XRVDGNKRPOAQTN-FQEVSTJZSA-N 5-[3-[(1s)-1-(2-hydroxyethylamino)-2,3-dihydro-1h-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile Chemical compound C1=C(C#N)C(OC(C)C)=CC=C1C1=NC(C=2C=3CC[C@@H](C=3C=CC=2)NCCO)=NO1 XRVDGNKRPOAQTN-FQEVSTJZSA-N 0.000 description 1
• WYWHKKSPHMUBEB-UHFFFAOYSA-N 6-Mercaptoguanine Natural products N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 1
• ZKRFOXLVOKTUTA-KQYNXXCUSA-N 9-(5-phosphoribofuranosyl)-6-mercaptopurine Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=S)=C2N=C1 ZKRFOXLVOKTUTA-KQYNXXCUSA-N 0.000 description 1
• 102000009062 ADP Ribose Transferases Human genes 0.000 description 1
• 108010049290 ADP Ribose Transferases Proteins 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 1
• 102000009185 Actin-filament associated proteins Human genes 0.000 description 1
• 108050000056 Actin-filament associated proteins Proteins 0.000 description 1
• 208000007848 Alcoholism Diseases 0.000 description 1
• 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 description 1
• 102100022712 Alpha-1-antitrypsin Human genes 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 1
• 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 1
• 206010002388 Angina unstable Diseases 0.000 description 1
• 108010049777 Ankyrins Proteins 0.000 description 1
• 102000008102 Ankyrins Human genes 0.000 description 1
• 102000018757 Apolipoprotein L1 Human genes 0.000 description 1
• 108010052469 Apolipoprotein L1 Proteins 0.000 description 1
• 101001125931 Arabidopsis thaliana Plastidial pyruvate kinase 2 Proteins 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 1
• 102100032435 BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 Human genes 0.000 description 1
• 102100028231 BTB/POZ domain-containing protein KCTD6 Human genes 0.000 description 1
• 102000012304 Bestrophin Human genes 0.000 description 1
• 108050002823 Bestrophin Proteins 0.000 description 1
• 101800001382 Betacellulin Proteins 0.000 description 1
• 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
• 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
• 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 1
• 102100021935 C-C motif chemokine 26 Human genes 0.000 description 1
• 102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 1
• 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 1
• 102000002086 C-type lectin-like Human genes 0.000 description 1
• 108050009406 C-type lectin-like Proteins 0.000 description 1
• 102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
• 102100021992 CD209 antigen Human genes 0.000 description 1
• 108010065524 CD52 Antigen Proteins 0.000 description 1
• 102100027217 CD82 antigen Human genes 0.000 description 1
• 108091064546 CNKSR family Proteins 0.000 description 1
• 102000038772 CNKSR family Human genes 0.000 description 1
• 102100035680 Cadherin EGF LAG seven-pass G-type receptor 2 Human genes 0.000 description 1
• 102000004631 Calcineurin Human genes 0.000 description 1
• 108010042955 Calcineurin Proteins 0.000 description 1
• 229940122739 Calcineurin inhibitor Drugs 0.000 description 1
• 101710192106 Calcineurin-binding protein cabin-1 Proteins 0.000 description 1
• 102100024123 Calcineurin-binding protein cabin-1 Human genes 0.000 description 1
• 102000003846 Carbonic anhydrases Human genes 0.000 description 1
• 108090000209 Carbonic anhydrases Proteins 0.000 description 1
• 102100028003 Catenin alpha-1 Human genes 0.000 description 1
• 101710106619 Catenin alpha-3 Proteins 0.000 description 1
• 102100028906 Catenin delta-1 Human genes 0.000 description 1
• 102100031118 Catenin delta-2 Human genes 0.000 description 1
• 101710180572 Catenin delta-2 Proteins 0.000 description 1
• 102000011068 Cdc42 Human genes 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 102000005598 Chondroitin Sulfate Proteoglycans Human genes 0.000 description 1
• 108010059480 Chondroitin Sulfate Proteoglycans Proteins 0.000 description 1
• 102000017589 Chromo domains Human genes 0.000 description 1
• 108050005811 Chromo domains Proteins 0.000 description 1
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
• 102000002029 Claudin Human genes 0.000 description 1
• 108050009302 Claudin Proteins 0.000 description 1
• 208000028698 Cognitive impairment Diseases 0.000 description 1
• 101710137434 Complexin-3 Proteins 0.000 description 1
• 102100027827 Complexin-3 Human genes 0.000 description 1
• 241000709687 Coxsackievirus Species 0.000 description 1
• 102100025278 Coxsackievirus and adenovirus receptor Human genes 0.000 description 1
• 208000006081 Cryptococcal meningitis Diseases 0.000 description 1
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
• 229930105110 Cyclosporin A Natural products 0.000 description 1
• 102000015833 Cystatin Human genes 0.000 description 1
• 102100029363 Cytochrome P450 2C19 Human genes 0.000 description 1
• 102100026234 Cytokine receptor common subunit gamma Human genes 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• 102100038076 DNA dC->dU-editing enzyme APOBEC-3G Human genes 0.000 description 1
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
• 101710096438 DNA-binding protein Proteins 0.000 description 1
• 102100037799 DNA-binding protein Ikaros Human genes 0.000 description 1
• 102100020986 DNA-binding protein RFX5 Human genes 0.000 description 1
• 102100039436 DNA-binding protein inhibitor ID-3 Human genes 0.000 description 1
• 206010012374 Depressed mood Diseases 0.000 description 1
• 102000006375 Desmocollins Human genes 0.000 description 1
• 108010019063 Desmocollins Proteins 0.000 description 1
• 102000011799 Desmoglein Human genes 0.000 description 1
• 108050002238 Desmoglein Proteins 0.000 description 1
• 102100034577 Desmoglein-3 Human genes 0.000 description 1
• 102100034573 Desmoglein-4 Human genes 0.000 description 1
• 239000004375 Dextrin Substances 0.000 description 1
• 229920001353 Dextrin Polymers 0.000 description 1
• 206010012689 Diabetic retinopathy Diseases 0.000 description 1
• 208000003024 Diffuse alopecia Diseases 0.000 description 1
• VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
• 206010013654 Drug abuse Diseases 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 102100039244 ETS-related transcription factor Elf-5 Human genes 0.000 description 1
• 102100030751 Eomesodermin homolog Human genes 0.000 description 1
• 101710142207 Eomesodermin homolog Proteins 0.000 description 1
• 102100023688 Eotaxin Human genes 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• 102100031559 Excitatory amino acid transporter 4 Human genes 0.000 description 1
• 102100028408 FERM and PDZ domain-containing protein 1 Human genes 0.000 description 1
• 108091008794 FGF receptors Proteins 0.000 description 1
• 102100030421 Fatty acid-binding protein 5 Human genes 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 1
• 102100037362 Fibronectin Human genes 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• 102000013366 Filamin Human genes 0.000 description 1
• 108060002900 Filamin Proteins 0.000 description 1
• 102100035144 Folate receptor beta Human genes 0.000 description 1
• 102100037042 Forkhead box protein E1 Human genes 0.000 description 1
• 101710088320 Forkhead box protein E1 Proteins 0.000 description 1
• 241001069765 Fridericia <angiosperm> Species 0.000 description 1
• 102100021262 Frizzled-3 Human genes 0.000 description 1
• 102100039799 Frizzled-6 Human genes 0.000 description 1
• 102100039676 Frizzled-7 Human genes 0.000 description 1
• 206010017533 Fungal infection Diseases 0.000 description 1
• WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
• 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
• 102100033713 Gamma-secretase subunit APH-1B Human genes 0.000 description 1
• SQSZANZGUXWJEA-UHFFFAOYSA-N Gandotinib Chemical compound N1C(C)=CC(NC2=NN3C(CC=4C(=CC(Cl)=CC=4)F)=C(C)N=C3C(CN3CCOCC3)=C2)=N1 SQSZANZGUXWJEA-UHFFFAOYSA-N 0.000 description 1
• 102100039401 Gap junction beta-6 protein Human genes 0.000 description 1
• HEMJJKBWTPKOJG-UHFFFAOYSA-N Gemfibrozil Chemical compound CC1=CC=C(C)C(OCCCC(C)(C)C(O)=O)=C1 HEMJJKBWTPKOJG-UHFFFAOYSA-N 0.000 description 1
• 208000009139 Gilbert Disease Diseases 0.000 description 1
• 208000022412 Gilbert syndrome Diseases 0.000 description 1
• 102000016354 Glucuronosyltransferase Human genes 0.000 description 1
• 108010092364 Glucuronosyltransferase Proteins 0.000 description 1
• 102000018899 Glutamate Receptors Human genes 0.000 description 1
• 108010027915 Glutamate Receptors Proteins 0.000 description 1
• 244000060234 Gmelina philippensis Species 0.000 description 1
• 102100030386 Granzyme A Human genes 0.000 description 1
• 102100035354 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 Human genes 0.000 description 1
• 108020004202 Guanylate Kinase Proteins 0.000 description 1
• 102000010437 HD domains Human genes 0.000 description 1
• 108050001906 HD domains Proteins 0.000 description 1
• 102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 description 1
• 108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 description 1
• 208000010496 Heart Arrest Diseases 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 208000007514 Herpes zoster Diseases 0.000 description 1
• 102100038006 High affinity immunoglobulin epsilon receptor subunit alpha Human genes 0.000 description 1
• 102100022103 Histone-lysine N-methyltransferase 2A Human genes 0.000 description 1
• 102100023607 Homer protein homolog 1 Human genes 0.000 description 1
• 102100023605 Homer protein homolog 2 Human genes 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101001017818 Homo sapiens ATP-dependent translocase ABCB1 Proteins 0.000 description 1
• 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 description 1
• 101000823116 Homo sapiens Alpha-1-antitrypsin Proteins 0.000 description 1
• 101000798415 Homo sapiens BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 Proteins 0.000 description 1
• 101001007228 Homo sapiens BTB/POZ domain-containing protein KCTD6 Proteins 0.000 description 1
• 101000946926 Homo sapiens C-C chemokine receptor type 5 Proteins 0.000 description 1
• 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 1
• 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
• 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 description 1
• 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 description 1
• 101000914469 Homo sapiens CD82 antigen Proteins 0.000 description 1
• 101000715674 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 2 Proteins 0.000 description 1
• 101000916264 Homo sapiens Catenin delta-1 Proteins 0.000 description 1
• 101000858031 Homo sapiens Coxsackievirus and adenovirus receptor Proteins 0.000 description 1
• 101001055227 Homo sapiens Cytokine receptor common subunit gamma Proteins 0.000 description 1
• 101000742736 Homo sapiens DNA dC->dU-editing enzyme APOBEC-3G Proteins 0.000 description 1
• 101000599038 Homo sapiens DNA-binding protein Ikaros Proteins 0.000 description 1
• 101001075432 Homo sapiens DNA-binding protein RFX5 Proteins 0.000 description 1
• 101001036287 Homo sapiens DNA-binding protein inhibitor ID-3 Proteins 0.000 description 1
• 101000924311 Homo sapiens Desmoglein-3 Proteins 0.000 description 1
• 101000924320 Homo sapiens Desmoglein-4 Proteins 0.000 description 1
• 101000813141 Homo sapiens ETS-related transcription factor Elf-5 Proteins 0.000 description 1
• 101000978392 Homo sapiens Eotaxin Proteins 0.000 description 1
• 101000866308 Homo sapiens Excitatory amino acid transporter 4 Proteins 0.000 description 1
• 101001060980 Homo sapiens FERM and PDZ domain-containing protein 1 Proteins 0.000 description 1
• 101001062855 Homo sapiens Fatty acid-binding protein 5 Proteins 0.000 description 1
• 101001023204 Homo sapiens Folate receptor beta Proteins 0.000 description 1
• 101000819458 Homo sapiens Frizzled-3 Proteins 0.000 description 1
• 101000885673 Homo sapiens Frizzled-6 Proteins 0.000 description 1
• 101000885797 Homo sapiens Frizzled-7 Proteins 0.000 description 1
• 101000733778 Homo sapiens Gamma-secretase subunit APH-1B Proteins 0.000 description 1
• 101000889125 Homo sapiens Gap junction beta-6 protein Proteins 0.000 description 1
• 101001009599 Homo sapiens Granzyme A Proteins 0.000 description 1
• 101001024316 Homo sapiens Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 Proteins 0.000 description 1
• 101000878611 Homo sapiens High affinity immunoglobulin epsilon receptor subunit alpha Proteins 0.000 description 1
• 101000898881 Homo sapiens Histone H2B type 1-O Proteins 0.000 description 1
• 101001045846 Homo sapiens Histone-lysine N-methyltransferase 2A Proteins 0.000 description 1
• 101001048469 Homo sapiens Homer protein homolog 1 Proteins 0.000 description 1
• 101001048464 Homo sapiens Homer protein homolog 2 Proteins 0.000 description 1
• 101000606465 Homo sapiens Inactive tyrosine-protein kinase 7 Proteins 0.000 description 1
• 101001046668 Homo sapiens Integrin alpha-X Proteins 0.000 description 1
• 101001050275 Homo sapiens Keratin, type I cuticular Ha1 Proteins 0.000 description 1
• 101001050271 Homo sapiens Keratin, type I cuticular Ha2 Proteins 0.000 description 1
• 101001026996 Homo sapiens Keratin, type I cuticular Ha3-II Proteins 0.000 description 1
• 101001007029 Homo sapiens Keratin, type II cuticular Hb2 Proteins 0.000 description 1
• 101000980823 Homo sapiens Leukocyte surface antigen CD53 Proteins 0.000 description 1
• 101001004953 Homo sapiens Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 description 1
• 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 description 1
• 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
• 101000577033 Homo sapiens Monocarboxylate transporter 7 Proteins 0.000 description 1
• 101000987113 Homo sapiens Monocarboxylate transporter 9 Proteins 0.000 description 1
• 101001125417 Homo sapiens Na(+)/H(+) exchange regulatory cofactor NHE-RF3 Proteins 0.000 description 1
• 101000979306 Homo sapiens Nectin-1 Proteins 0.000 description 1
• 101000655246 Homo sapiens Neutral amino acid transporter A Proteins 0.000 description 1
• 101001124309 Homo sapiens Nitric oxide synthase, endothelial Proteins 0.000 description 1
• 101001080825 Homo sapiens PH and SEC7 domain-containing protein 1 Proteins 0.000 description 1
• 101000955481 Homo sapiens Phosphatidylcholine translocator ABCB4 Proteins 0.000 description 1
• 101000583179 Homo sapiens Plakophilin-2 Proteins 0.000 description 1
• 101001026226 Homo sapiens Potassium voltage-gated channel subfamily KQT member 1 Proteins 0.000 description 1
• 101000877404 Homo sapiens Protein enabled homolog Proteins 0.000 description 1
• 101000609959 Homo sapiens Protein piccolo Proteins 0.000 description 1
• 101000845257 Homo sapiens Protein tweety homolog 2 Proteins 0.000 description 1
• 101000655540 Homo sapiens Protransforming growth factor alpha Proteins 0.000 description 1
• 101001121371 Homo sapiens Putative transcription factor Ovo-like 1 Proteins 0.000 description 1
• 101001074548 Homo sapiens Regulating synaptic membrane exocytosis protein 2 Proteins 0.000 description 1
• 101000700402 Homo sapiens Regulatory solute carrier protein family 1 member 1 Proteins 0.000 description 1
• 101000581125 Homo sapiens Rho-related GTP-binding protein RhoF Proteins 0.000 description 1
• 101001094082 Homo sapiens Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) Proteins 0.000 description 1
• 101000640823 Homo sapiens Sodium-coupled neutral amino acid transporter 3 Proteins 0.000 description 1
• 101000740122 Homo sapiens Sodium-dependent neutral amino acid transporter B(0)AT2 Proteins 0.000 description 1
• 101000693895 Homo sapiens Sodium/glucose cotransporter 4 Proteins 0.000 description 1
• 101000693265 Homo sapiens Sphingosine 1-phosphate receptor 1 Proteins 0.000 description 1
• 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 description 1
• 101000844519 Homo sapiens Transient receptor potential cation channel subfamily M member 6 Proteins 0.000 description 1
• 101000658574 Homo sapiens Transmembrane 4 L6 family member 1 Proteins 0.000 description 1
• 101001000119 Homo sapiens Unconventional myosin-If Proteins 0.000 description 1
• 101000760337 Homo sapiens Urokinase plasminogen activator surface receptor Proteins 0.000 description 1
• 101000867850 Homo sapiens Voltage-dependent T-type calcium channel subunit alpha-1G Proteins 0.000 description 1
• 241000725303 Human immunodeficiency virus Species 0.000 description 1
• 244000141009 Hypericum perforatum Species 0.000 description 1
• 235000017309 Hypericum perforatum Nutrition 0.000 description 1
• 206010020772 Hypertension Diseases 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• 238000004566 IR spectroscopy Methods 0.000 description 1
• 108091054729 IRF family Proteins 0.000 description 1
• 102100039813 Inactive tyrosine-protein kinase 7 Human genes 0.000 description 1
• 229940127449 Integrin Receptor Antagonists Drugs 0.000 description 1
• 102100022297 Integrin alpha-X Human genes 0.000 description 1
• 102000016854 Interferon Regulatory Factors Human genes 0.000 description 1
• 102000004551 Interleukin-10 Receptors Human genes 0.000 description 1
• 108010017550 Interleukin-10 Receptors Proteins 0.000 description 1
• 102000004560 Interleukin-12 Receptors Human genes 0.000 description 1
• 108010017515 Interleukin-12 Receptors Proteins 0.000 description 1
• 102000003812 Interleukin-15 Human genes 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 108010064064 Junctional Adhesion Molecules Proteins 0.000 description 1
• 102000014748 Junctional Adhesion Molecules Human genes 0.000 description 1
• 102100023131 Keratin, type I cuticular Ha1 Human genes 0.000 description 1
• 102100023127 Keratin, type I cuticular Ha2 Human genes 0.000 description 1
• 102100037376 Keratin, type I cuticular Ha3-II Human genes 0.000 description 1
• 102100040441 Keratin, type I cytoskeletal 16 Human genes 0.000 description 1
• 102100028339 Keratin, type II cuticular Hb2 Human genes 0.000 description 1
• 102100037381 Keratin, type II cuticular Hb5 Human genes 0.000 description 1
• 101710115522 Keratin, type II cuticular Hb5 Proteins 0.000 description 1
• 108010066364 Keratin-16 Proteins 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102000037126 Leucine-rich repeat-containing G-protein-coupled receptors Human genes 0.000 description 1
• 108091006332 Leucine-rich repeat-containing G-protein-coupled receptors Proteins 0.000 description 1
• 101710142062 Leukemia inhibitory factor receptor Proteins 0.000 description 1
• 102100024221 Leukocyte surface antigen CD53 Human genes 0.000 description 1
• 241000243684 Lumbricus Species 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102000004137 Lysophosphatidic Acid Receptors Human genes 0.000 description 1
• 108090000642 Lysophosphatidic Acid Receptors Proteins 0.000 description 1
• 102100040388 Lysophosphatidic acid receptor 3 Human genes 0.000 description 1
• 101710145716 Lysophosphatidic acid receptor 3 Proteins 0.000 description 1
• 102100037611 Lysophospholipase Human genes 0.000 description 1
• 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 1
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 108010031099 Mannose Receptor Proteins 0.000 description 1
• 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
• 206010027209 Meningitis cryptococcal Diseases 0.000 description 1
• 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
• QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
• 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 1
• 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 1
• 239000004909 Moisturizer Substances 0.000 description 1
• 102000010909 Monoamine Oxidase Human genes 0.000 description 1
• 108010062431 Monoamine oxidase Proteins 0.000 description 1
• 102100025311 Monocarboxylate transporter 7 Human genes 0.000 description 1
• 102100027861 Monocarboxylate transporter 9 Human genes 0.000 description 1
• 102000000562 Monocarboxylic Acid Transporters Human genes 0.000 description 1
• 101710204259 Monocarboxylic acid transporter Proteins 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101000715673 Mus musculus Cadherin EGF LAG seven-pass G-type receptor 2 Proteins 0.000 description 1
• 206010062207 Mycobacterial infection Diseases 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 102000047918 Myelin Basic Human genes 0.000 description 1
• 108700028031 Myelin Basic Proteins 0.000 description 1
• NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
• JOOXLOJCABQBSG-UHFFFAOYSA-N N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide Chemical compound N1=C(NC=2C=C(C=CC=2)S(=O)(=O)NC(C)(C)C)C(C)=CN=C1NC(C=C1)=CC=C1OCCN1CCCC1 JOOXLOJCABQBSG-UHFFFAOYSA-N 0.000 description 1
• 102000000812 NK Cell Lectin-Like Receptor Subfamily K Human genes 0.000 description 1
• 108010001657 NK Cell Lectin-Like Receptor Subfamily K Proteins 0.000 description 1
• 230000006051 NK cell activation Effects 0.000 description 1
• 102100029467 Na(+)/H(+) exchange regulatory cofactor NHE-RF3 Human genes 0.000 description 1
• 102100023064 Nectin-1 Human genes 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 102000002111 Neuropilin Human genes 0.000 description 1
• 108050009450 Neuropilin Proteins 0.000 description 1
• 102100032884 Neutral amino acid transporter A Human genes 0.000 description 1
• 244000061176 Nicotiana tabacum Species 0.000 description 1
• 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
• 208000014060 Niemann-Pick disease Diseases 0.000 description 1
• 102100028452 Nitric oxide synthase, endothelial Human genes 0.000 description 1
• 208000001388 Opportunistic Infections Diseases 0.000 description 1
• 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 description 1
• 101710137390 P-selectin glycoprotein ligand 1 Proteins 0.000 description 1
• 102100027472 PH and SEC7 domain-containing protein 1 Human genes 0.000 description 1
• 102000016462 Phosphate Transport Proteins Human genes 0.000 description 1
• 108010092528 Phosphate Transport Proteins Proteins 0.000 description 1
• 102100039032 Phosphatidylcholine translocator ABCB4 Human genes 0.000 description 1
• 108010058864 Phospholipases A2 Proteins 0.000 description 1
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
• 102100030348 Plakophilin-2 Human genes 0.000 description 1
• 102100030264 Pleckstrin Human genes 0.000 description 1
• 208000005384 Pneumocystis Pneumonia Diseases 0.000 description 1
• 206010073755 Pneumocystis jirovecii pneumonia Diseases 0.000 description 1
• 102100029740 Poliovirus receptor Human genes 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 102100037444 Potassium voltage-gated channel subfamily KQT member 1 Human genes 0.000 description 1
• 208000031951 Primary immunodeficiency Diseases 0.000 description 1
• 102100029837 Probetacellulin Human genes 0.000 description 1
• 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 102000003923 Protein Kinase C Human genes 0.000 description 1
• 108090000315 Protein Kinase C Proteins 0.000 description 1
• 102000005569 Protein Phosphatase 1 Human genes 0.000 description 1
• 108010059000 Protein Phosphatase 1 Proteins 0.000 description 1
• 102100037686 Protein SSX2 Human genes 0.000 description 1
• 101710149284 Protein SSX2 Proteins 0.000 description 1
• 102100035093 Protein enabled homolog Human genes 0.000 description 1
• 102100039154 Protein piccolo Human genes 0.000 description 1
• 102100031076 Protein tweety homolog 2 Human genes 0.000 description 1
• 102100032350 Protransforming growth factor alpha Human genes 0.000 description 1
• 208000003251 Pruritus Diseases 0.000 description 1
• 102100026326 Putative transcription factor Ovo-like 1 Human genes 0.000 description 1
• 102100024683 Ras-related protein R-Ras Human genes 0.000 description 1
• 101710094326 Ras-related protein R-Ras Proteins 0.000 description 1
• 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 1
• 101710151245 Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 1
• 102100036266 Regulating synaptic membrane exocytosis protein 2 Human genes 0.000 description 1
• 102100029521 Regulatory solute carrier protein family 1 member 1 Human genes 0.000 description 1
• 206010038910 Retinitis Diseases 0.000 description 1
• 102000041282 Rh family Human genes 0.000 description 1
• 108091061346 Rh family Proteins 0.000 description 1
• 102100027608 Rho-related GTP-binding protein RhoF Human genes 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 102000000395 SH3 domains Human genes 0.000 description 1
• 108050008861 SH3 domains Proteins 0.000 description 1
• 108091006976 SLC40A1 Proteins 0.000 description 1
• 206010054979 Secondary immunodeficiency Diseases 0.000 description 1
• 201000000860 Secondary syphilis Diseases 0.000 description 1
• 102000014105 Semaphorin Human genes 0.000 description 1
• 108050003978 Semaphorin Proteins 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 102000007073 Sialic Acid Binding Immunoglobulin-like Lectins Human genes 0.000 description 1
• 108010047827 Sialic Acid Binding Immunoglobulin-like Lectins Proteins 0.000 description 1
• 206010040639 Sick sinus syndrome Diseases 0.000 description 1
• 102100025795 Signal-regulatory protein gamma Human genes 0.000 description 1
• 101710092332 Signal-regulatory protein gamma Proteins 0.000 description 1
• 108010074687 Signaling Lymphocytic Activation Molecule Family Member 1 Proteins 0.000 description 1
• 102100029215 Signaling lymphocytic activation molecule Human genes 0.000 description 1
• 102100029942 Small cell adhesion glycoprotein Human genes 0.000 description 1
• 101710170111 Small cell adhesion glycoprotein Proteins 0.000 description 1
• 102100035258 Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) Human genes 0.000 description 1
• 102000008145 Sodium-Potassium-Chloride Symporters Human genes 0.000 description 1
• 108010074941 Sodium-Potassium-Chloride Symporters Proteins 0.000 description 1
• 102100033769 Sodium-coupled neutral amino acid transporter 3 Human genes 0.000 description 1
• 102100037252 Sodium-dependent neutral amino acid transporter B(0)AT2 Human genes 0.000 description 1
• 102100027214 Sodium/glucose cotransporter 4 Human genes 0.000 description 1
• 102100032008 Solute carrier family 40 member 1 Human genes 0.000 description 1
• 102100032889 Sortilin Human genes 0.000 description 1
• 102000005045 Sorting Nexin Human genes 0.000 description 1
• 229940127530 Sphingosine 1-Phosphate Receptor Modulators Drugs 0.000 description 1
• 102000009329 Sterile alpha motif domains Human genes 0.000 description 1
• 108050000172 Sterile alpha motif domains Proteins 0.000 description 1
• 208000006011 Stroke Diseases 0.000 description 1
• 102000004896 Sulfotransferases Human genes 0.000 description 1
• 108090001033 Sulfotransferases Proteins 0.000 description 1
• 102000001435 Synapsin Human genes 0.000 description 1
• 108050009621 Synapsin Proteins 0.000 description 1
• 230000006044 T cell activation Effects 0.000 description 1
• 102100037272 T cell receptor beta constant 1 Human genes 0.000 description 1
• 101710087279 T cell receptor beta constant 1 Proteins 0.000 description 1
• 102100034884 T cell receptor beta variable 19 Human genes 0.000 description 1
• 101710145551 T cell receptor beta variable 19 Proteins 0.000 description 1
• 102100022590 T cell receptor gamma constant 1 Human genes 0.000 description 1
• 101710081121 T cell receptor gamma constant 1 Proteins 0.000 description 1
• 102100022571 T cell receptor gamma constant 2 Human genes 0.000 description 1
• 101710081120 T cell receptor gamma constant 2 Proteins 0.000 description 1
• 102100022393 T cell receptor gamma variable 9 Human genes 0.000 description 1
• 101710151366 T cell receptor gamma variable 9 Proteins 0.000 description 1
• 102100029453 T-cell receptor-associated transmembrane adapter 1 Human genes 0.000 description 1
• 101710113863 T-cell receptor-associated transmembrane adapter 1 Proteins 0.000 description 1
• 102100035268 T-cell surface protein tactile Human genes 0.000 description 1
• QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
• 208000024799 Thyroid disease Diseases 0.000 description 1
• 206010043866 Tinea capitis Diseases 0.000 description 1
• 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 208000032109 Transient ischaemic attack Diseases 0.000 description 1
• 102100031231 Transient receptor potential cation channel subfamily M member 6 Human genes 0.000 description 1
• 102100034902 Transmembrane 4 L6 family member 1 Human genes 0.000 description 1
• 102000004271 Tryptophan 5-monooxygenases Human genes 0.000 description 1
• 108090000885 Tryptophan 5-monooxygenases Proteins 0.000 description 1
• 102100040213 UDP-glucuronosyltransferase 1A7 Human genes 0.000 description 1
• 101710205340 UDP-glucuronosyltransferase 1A7 Proteins 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 102000044159 Ubiquitin Human genes 0.000 description 1
• 102100035825 Unconventional myosin-If Human genes 0.000 description 1
• 208000007814 Unstable Angina Diseases 0.000 description 1
• 102100024689 Urokinase plasminogen activator surface receptor Human genes 0.000 description 1
• 206010046851 Uveitis Diseases 0.000 description 1
• 108010066342 Virus Receptors Proteins 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• 229930003316 Vitamin D Natural products 0.000 description 1
• QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
• 102100033024 Voltage-dependent T-type calcium channel subunit alpha-1G Human genes 0.000 description 1
• 241000269368 Xenopus laevis Species 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 108010084938 adenovirus receptor Proteins 0.000 description 1
• 206010001584 alcohol abuse Diseases 0.000 description 1
• 208000025746 alcohol use disease Diseases 0.000 description 1
• 102000012005 alpha-2-HS-Glycoprotein Human genes 0.000 description 1
• 108010075843 alpha-2-HS-Glycoprotein Proteins 0.000 description 1
• 239000003098 androgen Substances 0.000 description 1
• 239000003416 antiarrhythmic agent Substances 0.000 description 1
• 239000000935 antidepressant agent Substances 0.000 description 1
• 229940005513 antidepressants Drugs 0.000 description 1
• 208000037896 autoimmune cutaneous disease Diseases 0.000 description 1
• 230000006472 autoimmune response Effects 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• XUZMWHLSFXCVMG-UHFFFAOYSA-N baricitinib Chemical compound C1N(S(=O)(=O)CC)CC1(CC#N)N1N=CC(C=2C=3C=CNC=3N=CN=2)=C1 XUZMWHLSFXCVMG-UHFFFAOYSA-N 0.000 description 1
• 229940049706 benzodiazepine Drugs 0.000 description 1
• 150000001557 benzodiazepines Chemical class 0.000 description 1
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
• 108010057005 beta-galactoside alpha-2,3-sialyltransferase Proteins 0.000 description 1
• 230000008512 biological response Effects 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 239000010836 blood and blood product Substances 0.000 description 1
• 229940125691 blood product Drugs 0.000 description 1
• 238000010322 bone marrow transplantation Methods 0.000 description 1
• 229940112869 bone morphogenetic protein Drugs 0.000 description 1
• QWCRAEMEVRGPNT-UHFFFAOYSA-N buspirone Chemical compound C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 QWCRAEMEVRGPNT-UHFFFAOYSA-N 0.000 description 1
• 229960002495 buspirone Drugs 0.000 description 1
• 229940046731 calcineurin inhibitors Drugs 0.000 description 1
• 102000028861 calmodulin binding Human genes 0.000 description 1
• 108091000084 calmodulin binding Proteins 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 239000007963 capsule composition Substances 0.000 description 1
• FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
• 229960000623 carbamazepine Drugs 0.000 description 1
• 230000000747 cardiac effect Effects 0.000 description 1
• 230000001269 cardiogenic effect Effects 0.000 description 1
• 230000009084 cardiovascular function Effects 0.000 description 1
• 108010051348 cdc42 GTP-Binding Protein Proteins 0.000 description 1
• 229950006295 cerdulatinib Drugs 0.000 description 1
• DREIJXJRTLTGJC-ZLBJMMTISA-N chembl3137308 Chemical compound C([C@H]1C[C@@](O)(C2)C3)C2C[C@H]3[C@H]1NC1=C2C=CNC2=NC=C1C(=O)N DREIJXJRTLTGJC-ZLBJMMTISA-N 0.000 description 1
• FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
• 208000020832 chronic kidney disease Diseases 0.000 description 1
• GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
• 229960003009 clopidogrel Drugs 0.000 description 1
• 239000011280 coal tar Substances 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 208000010877 cognitive disease Diseases 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 239000002131 composite material Substances 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 238000000315 cryotherapy Methods 0.000 description 1
• 238000011461 current therapy Methods 0.000 description 1
• 238000005520 cutting process Methods 0.000 description 1
• WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
• 229960004397 cyclophosphamide Drugs 0.000 description 1
• 108050004038 cystatin Proteins 0.000 description 1
• 108010012052 cytochrome P-450 CYP2C subfamily Proteins 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• 239000000850 decongestant Substances 0.000 description 1
• 229940124581 decongestants Drugs 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 235000019425 dextrin Nutrition 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 239000007884 disintegrant Substances 0.000 description 1
• 238000001647 drug administration Methods 0.000 description 1
• 229940000406 drug candidate Drugs 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 239000003974 emollient agent Substances 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• 102000015694 estrogen receptors Human genes 0.000 description 1
• 108010038795 estrogen receptors Proteins 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000028023 exocytosis Effects 0.000 description 1
• 239000003889 eye drop Substances 0.000 description 1
• 229940012356 eye drops Drugs 0.000 description 1
• 210000004709 eyebrow Anatomy 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 230000003645 female-pattern hair loss Effects 0.000 description 1
• 229950006663 filgotinib Drugs 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 210000004904 fingernail bed Anatomy 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
• 229960004884 fluconazole Drugs 0.000 description 1
• 229960000390 fludarabine Drugs 0.000 description 1
• GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
• 229950008908 gandotinib Drugs 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 239000007903 gelatin capsule Substances 0.000 description 1
• 229960003627 gemfibrozil Drugs 0.000 description 1
• 230000004547 gene signature Effects 0.000 description 1
• 230000024924 glomerular filtration Effects 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
• 102000006638 guanylate kinase Human genes 0.000 description 1
• 210000004524 haematopoietic cell Anatomy 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
• 238000002017 high-resolution X-ray diffraction Methods 0.000 description 1
• 238000001794 hormone therapy Methods 0.000 description 1
• IWBJJCOKGLUQIZ-HQKKAZOISA-N hyperforin Chemical compound OC1=C(CC=C(C)C)C(=O)[C@@]2(CC=C(C)C)C[C@H](CC=C(C)C)[C@](CCC=C(C)C)(C)[C@]1(C(=O)C(C)C)C2=O IWBJJCOKGLUQIZ-HQKKAZOISA-N 0.000 description 1
• QOVWXXKVLJOKNW-UHFFFAOYSA-N hyperforin Natural products CC(C)C(=O)C12CC(CC=C(C)C)(CC(CC=C(C)C)C1CCC=C(C)C)C(=C(CC=C(C)C)C2=O)O QOVWXXKVLJOKNW-UHFFFAOYSA-N 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 239000002955 immunomodulating agent Substances 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 208000033065 inborn errors of immunity Diseases 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 230000004968 inflammatory condition Effects 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 201000004332 intermediate coronary syndrome Diseases 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 230000005722 itchiness Effects 0.000 description 1
• 230000003780 keratinization Effects 0.000 description 1
• 102000027041 kinase binding proteins Human genes 0.000 description 1
• 108091008508 kinase binding proteins Proteins 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 229950001845 lestaurtinib Drugs 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 229940124590 live attenuated vaccine Drugs 0.000 description 1
• 229940023012 live-attenuated vaccine Drugs 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 230000000527 lymphocytic effect Effects 0.000 description 1
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
• 230000003273 male-pattern hair loss Effects 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 239000003475 metalloproteinase inhibitor Substances 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
• 238000007431 microscopic evaluation Methods 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000001333 moisturizer Effects 0.000 description 1
• ZVHNDZWQTBEVRY-UHFFFAOYSA-N momelotinib Chemical compound C1=CC(C(NCC#N)=O)=CC=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCOCC2)=N1 ZVHNDZWQTBEVRY-UHFFFAOYSA-N 0.000 description 1
• 229940014456 mycophenolate Drugs 0.000 description 1
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
• 210000000066 myeloid cell Anatomy 0.000 description 1
• 208000010125 myocardial infarction Diseases 0.000 description 1
• RIJLVEAXPNLDTC-UHFFFAOYSA-N n-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide Chemical compound C1CC1C(=O)NC(=NN12)N=C1C=CC=C2C(C=C1)=CC=C1CN1CCS(=O)(=O)CC1 RIJLVEAXPNLDTC-UHFFFAOYSA-N 0.000 description 1
• 210000000282 nail Anatomy 0.000 description 1
• 208000026721 nail disease Diseases 0.000 description 1
• 239000007922 nasal spray Substances 0.000 description 1
• 229960005027 natalizumab Drugs 0.000 description 1
• 102000039446 nucleic acids Human genes 0.000 description 1
• 108020004707 nucleic acids Proteins 0.000 description 1
• 150000007523 nucleic acids Chemical class 0.000 description 1
• 102000026415 nucleotide binding proteins Human genes 0.000 description 1
• 108091014756 nucleotide binding proteins Proteins 0.000 description 1
• 231100000862 numbness Toxicity 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• 229940127249 oral antibiotic Drugs 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 210000004789 organ system Anatomy 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 229940027035 oxsoralen Drugs 0.000 description 1
• 229950008141 ozanimod Drugs 0.000 description 1
• HWXVIOGONBBTBY-ONEGZZNKSA-N pacritinib Chemical compound C=1C=C(C=2)NC(N=3)=NC=CC=3C(C=3)=CC=CC=3COC\C=C\COCC=2C=1OCCN1CCCC1 HWXVIOGONBBTBY-ONEGZZNKSA-N 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 239000001814 pectin Substances 0.000 description 1
• 229920001277 pectin Polymers 0.000 description 1
• 235000010987 pectin Nutrition 0.000 description 1
• 229950005157 peficitinib Drugs 0.000 description 1
• 235000019271 petrolatum Nutrition 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 108010026735 platelet protein P47 Proteins 0.000 description 1
• 108050009312 plexin Proteins 0.000 description 1
• 102000002022 plexin Human genes 0.000 description 1
• 201000000317 pneumocystosis Diseases 0.000 description 1
• 108010048507 poliovirus receptor Proteins 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 238000004321 preservation Methods 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000003449 preventive effect Effects 0.000 description 1
• 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 108020003519 protein disulfide isomerase Proteins 0.000 description 1
• 238000000575 proteomic method Methods 0.000 description 1
• 208000020016 psychiatric disease Diseases 0.000 description 1
• 238000001671 psychotherapy Methods 0.000 description 1
• 208000005069 pulmonary fibrosis Diseases 0.000 description 1
• 238000007388 punch biopsy Methods 0.000 description 1
• 108700042226 ras Genes Proteins 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 230000001177 retroviral effect Effects 0.000 description 1
• HFNKQEVNSGCOJV-OAHLLOKOSA-N ruxolitinib Chemical group C1([C@@H](CC#N)N2N=CC(=C2)C=2C=3C=CNC=3N=CN=2)CCCC1 HFNKQEVNSGCOJV-OAHLLOKOSA-N 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 201000002932 second-degree atrioventricular block Diseases 0.000 description 1
• 230000001235 sensitizing effect Effects 0.000 description 1
• 208000002491 severe combined immunodeficiency Diseases 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 229950005693 siponimod Drugs 0.000 description 1
• 208000020352 skin basal cell carcinoma Diseases 0.000 description 1
• 208000017520 skin disease Diseases 0.000 description 1
• 201000010106 skin squamous cell carcinoma Diseases 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• 108010014657 sortilin Proteins 0.000 description 1
• 108060007774 sorting nexin Proteins 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• PWEBUXCTKOWPCW-UHFFFAOYSA-N squaric acid Chemical compound OC1=C(O)C(=O)C1=O PWEBUXCTKOWPCW-UHFFFAOYSA-N 0.000 description 1
• XBRWELTXMQSEIN-UHFFFAOYSA-N squaric acid dibutyl ester Chemical compound CCCCOC1=C(OCCCC)C(=O)C1=O XBRWELTXMQSEIN-UHFFFAOYSA-N 0.000 description 1
• 229940071117 starch glycolate Drugs 0.000 description 1
• 208000011117 substance-related disease Diseases 0.000 description 1
• 230000000475 sunscreen effect Effects 0.000 description 1
• 239000000516 sunscreening agent Substances 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 210000002182 synaptic membrane Anatomy 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 229940037128 systemic glucocorticoids Drugs 0.000 description 1
• 230000035488 systolic blood pressure Effects 0.000 description 1
• 239000002278 tabletting lubricant Substances 0.000 description 1
• 229960001967 tacrolimus Drugs 0.000 description 1
• QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
• 201000001297 telogen effluvium Diseases 0.000 description 1
• 201000002931 third-degree atrioventricular block Diseases 0.000 description 1
• DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 229960003087 tioguanine Drugs 0.000 description 1
• 210000001519 tissue Anatomy 0.000 description 1
• 210000004906 toe nail Anatomy 0.000 description 1
• 239000003860 topical agent Substances 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• 201000010875 transient cerebral ischemia Diseases 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 208000002271 trichotillomania Diseases 0.000 description 1
• 241000701161 unidentified adenovirus Species 0.000 description 1
• 235000019166 vitamin D Nutrition 0.000 description 1
• 239000011710 vitamin D Substances 0.000 description 1
• 150000003710 vitamin D derivatives Chemical class 0.000 description 1
• 229940046008 vitamin d Drugs 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1